A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas

British Journal of Cancer

Volumn 107, Issue 6, 2012, Pages 994-1000

  Dom, G ^a   Tarabichi, M ^a   Unger, K ^b   Thomas, G ^b   Oczko Wojciechowska, M ^c   Bogdanova, T ^d   Jarzab, B ^c   Dumont, J E ^a   Detours, V ^a   Maenhaut, C ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

Author keywords

Chernobyl; gene expression; radiation; thyroid

Indexed keywords

MESSENGER RNA;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CHERNOBYL ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA; UKRAINE;

ADOLESCENT; CHERNOBYL NUCLEAR ACCIDENT; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DIET; DISEASE SUSCEPTIBILITY; GENE EXPRESSION PROFILING; HUMANS; INFANT; IODINE; NEOPLASMS, RADIATION-INDUCED; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; UKRAINE; YOUNG ADULT;

EID: 84865866443     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.302     Document Type: Article

References (42)

1. Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD, Burnet NG (2009) Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 9(2): 134-142
2. Baverstock K, Egloff B, Pinchera A, Ruchti C, Williams D (1992) Thyroidcancer after Chernobyl. Nature 359(6390): 21-22
3. Bourguignon MH, Gisone PA, Perez MR, Michelin S, Dubner D, Giorgio MD, Carosella ED (2005) Genetic and epigenetic features in radiation sensitivity Part I: cell signalling in radiation response. Eur J Nucl Med Mol Imaging 32(2): 229-246
4. Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, Karchin R, Kinzler KW, Vogelstein B, Nowak MA (2010) Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci USA 107(43): 18545-18550
5. Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov O, Bouville A, Goulko G, Hoshi M, Abrosimov A, Anoshko J, Astakhova L, Chekin S, Demidchik E, Galanti R, Ito M, Korobova E, Lushnikov E, Maksioutov M, Masyakin V, Nerovnia A, Parshin V, Parshkov E, Piliptsevich N, Pinchera A, Polyakov S, Shabeka N, Suonio E, Tenet V, Tsyb A, Yamashita S, Williams D (2005) Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 97(10): 724-732
6. Chuang EY, Chen X, Tsai MH, Yan H, Li CY, Mitchell JB, Nagasawa H, Wilson PF, Peng Y, Fitzek MM, Bedford JS, Little JB (2006) Abnormal gene expression profiles in unaffected parents of patients with hereditary-type retinoblastoma. Cancer Res 66(7): 3428-3433
7. Coclet J, Foureau F, Ketelbant P, Galand P, Dumont JE (1989) Cell population kinetics in dog and human adult thyroid. Clin Endocrinol 31(6): 655-665
8. Cohen J, Xing MZ, Mambo E, Guo ZM, Wu GG, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D (2003) BRAF mutation in papillary thyroid carcinoma. J. Natl Cancer Inst 95(8): 625-627
9. Delys L, Detours V, Franc B, Thomas G, Bogdanova T, Tronko M, Libert F, Dumont JE, Maenhaut C (2007) Gene expression and the biological phenotype of papillary thyroid carcinomas. Oncogene 26(57): 7894-7903
10. Dennis Jr. G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4(5): 3
11. Detours V, Delys L, Libert F, Weiss SD, Bogdanova T, Dumont JE, Franc B, Thomas G, Maenhaut C (2007) Genome-wide gene expression profiling suggests distinct radiation susceptibilities in sporadic and post-Chernobyl papillary thyroid cancers. Br J Cancer 97(6): 818-825
12. Detours V, Wattel S, Venet D, Hutsebaut N, Bogdanova T, Tronko MD, Dumont JE, Franc B, Thomas G, Maenhaut C (2005) Absence of a specific radiation signature in post-Chernobyl thyroid cancers. Br J Cancer 92(8): 1545-1552
13. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la CA, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K (2009) Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41(4): 460-464
14. Harper JW, Elledge SJ (2007) The DNA damage response: ten years after. Mol Cell 28(5): 739-745
15. Hayashi Y, Lagarde F, Tsuda N, Funamoto S, Preston DL, Koyama K, Mabuchi K, Ron E, Kodama K, Tokuoka S (2010) Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk. Cancer 116(7): 1646-1655
16. Hebrant A, Van Sande J, Roger PP, Patey M, Klein M, Bournaud C, Savagner F, Leclere J, Dumont JE, van Staveren WC, Maenhaut C (2009) Thyroid gene expression in familial nonautoimmune hyperthyroidism shows common characteristics with hyperfunctioning autonomous adenomas. J Clin Endocrinol Metab 94(7): 2602-2609
17. Hess J, Thomas G, Braselmann H, Bauer V, Bogdanova T, Wienberg J, Zitzelsberger H, Unger K (2011) Gain of chromosome band 7q11 in papillary thyroid carcinomas of young patients is associated with exposure to low-dose irradiation. Proc Natl Acad Sci USA 108(23): 9595-9600
18. Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellegata NS, De La Chapelle A (2001) Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA 98(26): 15044-15049
19. Jarzab B, Handkiewicz-Junak D, Wloch J (2005a) Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer 12(4): 773-803
20. Jarzab B, Wiench M, Fujarewicz K, Simek K, Jarzab M, Oczko-Wojciechowska M, Wloch J, Czarniecka A, Chmielik E, Lange D, Pawlaczek A, Szpak S, Gubala E, Swierniak A (2005b) Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res 65(4): 1587-1597
21. Kimura ET, Nikiforova MN, Zhu ZW, Knauf JA, Nikiforov YE, Fagin JA (2003) High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63(7): 1454-1457
22. Liaw A. (2011) Classification and Regression by Random Forest. Wiener M, R News 2/3, 18-22, 12-1-2011
23. Maenhaut C, Detours V, Dom G, Handkiewicz-Junak D, Oczko-Wojciechowska M, Jarzab B (2011) Gene expression profiles for radiationinduced thyroid cancer. Clin Oncol 23(4): 282-288
24. Malone J, Unger J, Delange F, Lagasse R, Dumont JE (1991) Thyroid consequences of Chernobyl accident in the countries of the European community. JEndocrinol Invest 14(8): 701-717
25. Meyer D. (2011) Support Vector Machines. The interface to libsvm in package e1070. 1-7, 5-22-2011 Nikiforov YE (2002) RET/PTC rearrangement in thyroid tumors. Endocr Pathol 13(1): 3-16
26. Port M, Boltze C, Wang Y, Roper B, Meineke V, Abend M (2007) A radiation-induced gene signature distinguishes post-Chernobyl from sporadic papillary thyroid cancers. Radiat Res 168(6): 639-649
27. Powell N, Jeremiah S, Morishita M, Dudley E, Bethel J, Bogdanova T, Tronko M, Thomas G (2005) Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure. J Pathol 205(5): 558-564
28. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP (2006) GenePattern 2.0. Nat Genet 38(5): 500-501
29. Riley T, Sontag E, Chen P, Levine A (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9(5): 402-412
30. Ruschhaupt M. (2004) A compendium to ensure computational reproducibility in high-dimensional classification tasks. In Statistical Applications in Genetics and Molecular Biology, Huber W, Poutska A, Mansmann U (eds). Vol. 3, Issue 1, Article 37
31. Saad AG, Kumar S, Ron E, Lubin JH, Stanek J, Bove KE, Nikiforov YE (2006) Proliferative activity of human thyroid cells in various age groups and its correlation with the risk of thyroid cancer after radiation exposure. J Clin Endocrinol Metab 91(7): 2672-2677
32. Smirnov DA, Morley M, Shin E, Spielman RS, Cheung VG (2009) Genetic analysis of radiation-induced changes in human gene expression. Nature 459(7246): 587-591
33. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R, Sobrinho-Simoes M (2003) BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22(29): 4578-4580
34. Stein L, Rothschild J, Luce J, Cowell JK, Thomas G, Bogdanova TI, Tronko MD, Hawthorn L (2010) Copy number and gene expression alterations in radiation-induced papillary thyroid carcinoma from Chernobyl pediatric patients. Thyroid 20(5): 475-487
35. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43): 15545-15550
36. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, Takigawa-Imamura H, Akulevich NM, Ratanajaraya C, Mitsutake N, Takamura N, Danilova LI, Lushchik ML, Demidchik YE, Heath S, Yamada R, Lathrop M, Matsuda F, Yamashita S (2010) The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 19(12): 2516-2523
37. Tamayo P, Scanfeld D, Ebert BL, Gillette MA, Roberts CW, Mesirov JP (2007) Metagene projection for cross-platform, cross-species characterization of global transcriptional states. Proc Natl Acad Sci USA 104(14): 5959-5964
38. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98(9): 5116-5121
39. Ugolin N, Ory C, Lefevre E, Benhabiles N, Hofman P, Schlumberger M, Chevillard S (2011) Strategy to find molecular signatures in a small series of rare cancers: validation for radiation-induced breast and thyroid tumors. PLoS One 6(8): e23581
40. Williams ED, Abrosimov A, Bogdanova T, Demidchik EP, Ito M, LiVolsi V, Lushnikov E, Rosai J, Sidorov Y, Tronko MD, Tsyb AF, Vowler SL, Thomas GA (2004) Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br J Cancer 90(11): 2219-2224
41. Williams ED, Abrosimov A, Bogdanova T, Demidchik EP, Ito M, LiVolsi V, Lushnikov E, Rosai J, Tronko MD, Tsyb AF, Vowler SL, Thomas GA (2008) Morphologic characteristics of Chernobyl-related childhood papillary thyroid carcinomas are independent of radiation exposure but vary with iodine intake. Thyroid 18(8): 847-852
42. Xing M (2005) BRAF mutation in thyroid cancer. Endocr Relat Cancer 12(2): 245-262